ESC 365 - Antiplatelet agents and DOACs in primary and secondary prevention.

Open Access

Antiplatelet agents and DOACs in primary and secondary prevention.

Session: Session 8: Primary and Secondary Prevention in Women - Lipid Lowering Agents, Anti-Diabetic Drugs - Antiplatelet Therapy and Anticoagulation

Topic: Pharmacology and Pharmacotherapy

Event: Cardiovascular Pharmacotherapy in Women 2022

Seminar Presentation

2 more presentations in this session

Management of dyslipidaemia.

Speaker: Professor H. Drexel (Feldkirch, AT)

Diabetes, obesity, uric acid.

Speaker: Professor G. Derumeaux (Creteil, FR)

Access the full session

Session 8: Primary and Secondary Prevention in Women - Lipid Lowering Agents, Anti-Diabetic Drugs - Antiplatelet Therapy and Anticoagulation

Speakers: Professor H. Drexel, Professor G. Derumeaux

About the event

Cardiovascular Pharmacotherapy in Women 2022

17 February - 18 February 2022

Seminar

ESC 365 is supported by